Phase 2 Chronic Kidney Disease Stage 3 Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)
Chronic Kidney Disease Stage 3
AION Healthspan, Inc.36 enrolled2 locationsNCT06721143
Recruiting
Phase 2
Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)
Metabolic Dysfunction-Associated SteatohepatitisChronic Kidney Disease Stage 3Chronic Kidney Disease Stage 2
Enyo Pharma60 enrolled1 locationNCT06939816
Recruiting
Phase 2
A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.
Chronic Kidney Disease Stage 3Chronic Renal FailureMechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis+1 more
Klinikum Nürnberg100 enrolled2 locationsNCT05884866